Form 13-F position report

UNITEDHEALTH GROUP INC

Reported by Legal & General Group Plc

UNH CUSIP 91324P102 Manager CIK 0000764068

Reported 6,804,160 shares, up 131,179 (2.0%) from the prior quarter.

Reported value 6.5%; share count 2.0% vs. the prior quarter.

Added
% of reported 13F value 1.11% This manager · Q4 2023
Shares 6,804,160 Quarter-end amount reported
Reported value $3,582,203,847 Fair value at quarter end
Consecutive quarters held 43 Through Q4 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-09-30 2528792000
2021-12-31 3181319000
2022-03-31 3478270000
2022-06-30 3576829000
2022-09-30 3427624000
2022-12-31 3515997283
2023-03-31 3152097956
2023-06-30 3338475823
2023-09-30 3364452938
2023-12-31 3582203847
2024-03-31 3347047092
2024-06-30 3242818798
2024-09-30 3778338896
2024-12-31 3038680779
2025-03-31 3118293332
2025-06-30 1876936617
2025-09-30 2162182282
2025-12-31 2000201523
2026-03-31 1655752116
2026-06-30 2444927690

Quarterly position history

How this manager's reported quarter-end position changed over time.

20 quarters
Quarterly reported position history for UNITEDHEALTH GROUP INC held by Legal & General Group Plc.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q2 2026 Reduced 5,882,462 -236,582 (-3.9%) 0.51% $2,444,927,690 2026-08-14
Q1 2026 Added 6,119,044 +59,847 (1.0%) 0.38% $1,655,752,116 2026-05-08
Q4 2025 Reduced 6,059,197 -202,553 (-3.2%) 0.44% $2,000,201,523 2026-02-09
Q3 2025 Added 6,261,750 +245,349 (4.1%) 0.49% $2,162,182,282 2025-11-13
Q2 2025 Added 6,016,401 +62,619 (1.1%) 0.47% $1,876,936,617 2025-08-12
Q1 2025 Reduced 5,953,782 -53,178 (-0.9%) 0.85% $3,118,293,332 2025-05-15
Q4 2024 Reduced 6,006,960 -455,279 (-7.0%) 0.8% $3,038,680,779 2025-02-13
Q3 2024 Added 6,462,239 +94,527 (1.5%) 0.99% $3,778,338,896 2024-11-14
Q2 2024 Reduced 6,367,712 -398,121 (-5.9%) 0.92% $3,242,818,798 2024-08-14
Q1 2024 Reduced 6,765,833 -38,327 (-0.6%) 0.96% $3,347,047,092 2024-05-14
Q4 2023 Added 6,804,160 +131,179 (2.0%) 1.11% $3,582,203,847 2024-02-15
Q3 2023 Reduced 6,672,981 -272,928 (-3.9%) 1.17% $3,364,452,938 2023-11-14
Q2 2023 Added 6,945,909 +276,057 (4.1%) 1.09% $3,338,475,823 2023-08-14
Q1 2023 Added 6,669,852 +38,150 (0.6%) 1.13% $3,152,097,956 2023-05-15
Q4 2022 Reduced 6,631,702 -155,107 (-2.3%) 1.35% $3,515,997,283 2023-02-14
Q3 2022 Reduced 6,786,809 -176,963 (-2.5%) 1.34% $3,427,624,000 2022-11-14
Q2 2022 Added 6,963,772 +143,238 (2.1%) 1.27% $3,576,829,000 2022-08-22
Q1 2022 Added 6,820,534 +485,012 (7.7%) 1.06% $3,478,270,000 2022-05-16
Q4 2021 Reduced 6,335,522 -136,278 (-2.1%) 0.96% $3,181,319,000 2022-02-14
Q3 2021 Added 6,471,800 +222,200 (3.6%) 0.82% $2,528,792,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

3507 managers reported UNITEDHEALTH GROUP INC for Q4 2023.

Managers reporting UNITEDHEALTH GROUP INC in Q4 2023.
Manager Activity Shares Change % of reported 13F Reported value Tenure
VANGUARD GROUP INC Added 83,860,515 +250,291 0.96% $44,150,045,336 43 qtrs
BlackRock Inc Reduced 72,376,243 -550,472 0.97% $38,103,920,724 43 qtrs
STATE STREET CORPORATION Added 45,518,920 +1,091,436 1.17% $23,964,345,812 43 qtrs
FMR LLC Reduced 41,729,708 -1,764,595 1.69% $21,969,438,861 43 qtrs
Capital World Investors Added 28,862,345 +9,093 2.7% $15,195,074,675 43 qtrs
PRICE T ROWE ASSOCIATES INC MD Reduced 25,968,287 -789,861 1.84% $13,671,525,000 43 qtrs
WELLINGTON MANAGEMENT GROUP LLP Reduced 24,392,706 -827,528 2.39% $12,842,027,928 43 qtrs
JPMorgan Chase & Co Added 23,948,592 +624,974 1.21% $12,608,664,730 43 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 18,213,348 +343,363 1.0% $9,563,078,705 43 qtrs
MORGAN STANLEY Added 16,777,571 +1,060,684 0.78% $8,832,889,453 43 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
December 31, 2023
Filed
February 15, 2024
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
5,819,925
Shared
0
None
984,235

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.